Some positive news for us - the text below is copied from page 7 in the report:-
"Follow up compounds to PBT434 are being designed not only from the quinazolinone class but also from additional chemical classes to offer differentiated functional pharmacodynamic and pharmacokinetic characteristics."
Some positive news for us - the text below is copied from page 7...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.5¢ | $501.4K | 91.10M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 71 | 70438990 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 7499794 | 14 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.6¢ |
Change
-0.001 ( 8.33 %) |
||||
| Open | High | Low | Volume | ||
| 0.6¢ | 0.6¢ | 0.6¢ | 3568393 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| ATH (ASX) Chart |